Xylazine Use Among People Who Inject Drugs, Philadelphia 2022

04/24/24 • 13 min

Host Shawn McNiel, MD, is joined by Marissa Tan, DO, an Epidemiology Intelligence Service (EIS) Fellow for the Center of Disease Control and Prevention through the Philadelphia Department of Public Health. Dr. Tan and her co-authors sought to help clinicians better identify individuals at risk and inform patients and clinicians about xylazine risk factors.

Dr. Tan discusses their findings from National HIV Behavioral Surveillance Survey among persons who inject drugs data and offers recommendations for clinicians and public health professionals.

Show Links:

Xylazine Use Among People Who Inject Drugs, Philadelphia 2022

Journal of Addiction Medicine, 18(2):p 194-200, 3/4 2024.

March-April 2024

Xylazine Use Among People Who Inject Drugs, Philadelphia 2022

Dr. Tan discusses their findings from National HIV Behavioral Surveillance Survey among persons who inject drugs data and offers recommendations for clinicians and public health professionals.

Show Links:

Xylazine Use Among People Who Inject Drugs, Philadelphia 2022

Journal of Addiction Medicine, 18(2):p 194-200, 3/4 2024.

March-April 2024

Previous Episode

Exploring the Impact of Opioid Settlements on Addiction Medicine

Podcast host Shawn McNeil, MD, is joined by Joshua Sharfstein, MD, and Sara Whaley, MPH, from Johns Hopkins Bloomberg School of Public Health who delve into the strategic allocation of $56 billion from opioid litigation settlements. As they discuss the principles for effective fund utilization, they highlight opportunities for addiction medicine specialists to play a pivotal role in guiding state and local governments to spend these resources wisely to save lives.

Journal of Addiction Medicine, November-December 2023

Opioid Settlements: The Role for Addiction Medicine in Guiding Effective Spending

Also of Interest

Principles for the Use of Funds From the Opioid Litigation

Developed by a coalition of organizations across the spectrum of the substance use field including physicians, addiction medicine specialists, recovery, treatment, and harm reduction.

Next Episode

Hospital Initiatives to Transition SUD Patients from Acute Care to Community-based Services

Podcast host Shawn McNiel, MD, is joined by Noa Krawczyk, PhD, an assistant professor in the Department of Population Health at NYU Grossman School of Medicine, and an author of Initiatives to Support the Transition of Patients With Substance Use Disorders From Acute Care to Community-based Services Among a National Sample of Nonprofit Hospitals. Dr. Krawczyk discusses the gap in transition of acute care to community care services among most US hospitals, efforts to increase acute care interventions, and how clinicians providing SUD treatment can help hospitals identify and implement best practices to support continuity of care.

Follow Dr. Krawczyk on Twitter @noakrawczyk

Article, Authors, and Links:

Initiatives to Support the Transition of Patients With Substance Use Disorders From Acute Care to Community-based Services Among a National Sample of Nonprofit Hospitals.

Krawczyk, Noa PhD; Rivera, Bianca D. MPH; Chang, Ji E. PhD; Lindenfeld, Zoe MPH; Franz, Berkeley PhD

Journal of Addiction Medicine 18(2):p 115-121, 3/4 2024